Gene · 1584
Papers2,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-modal characterization of metabolic and immune gene clusters in adrenocortical carcinoma treatment. | NPJ Precis Oncol | 2025 | 40968257 | PubTator, text mining | PubMed |
| Glucocorticoid Remediable Aldosteronism in a Family with a Strong History of Cerebral Aneurysms and Hypertension. | Prague Med Rep | 2025 | 40966436 | PubTator, text mining | PubMed |
| [The relationship between surgical outcomes and KCNJ5 mutations and pathological classification in patients with unilateral primary aldosteronism]. | Zhonghua Xin Xue Guan Bing Za Zhi | 2025 | 40953986 | PubTator, text mining | PubMed |
| Aldosterone synthase inhibition: a novel bullet to fight cardiovascular-kidney-metabolic syndrome. | J Mol Endocrinol | 2025 | 40911485 | PubTator, text mining | PubMed |
| First intragenic inversion of CYP11B1 gene causing 11β-hydroxylase deficiency: a molecular diagnosis easily overlooked. | J Med Genet | 2025 | 40819900 | PubTator, text mining | PubMed |
| 21-deoxycortisol as a second-tier test in congenital adrenal hyperplasia newborn screening in The Netherlands: two-year evaluation. | Arch Dis Child | 2025 | 40780708 | PubTator, text mining | PubMed |
| Hyperandrogenism-induced Athletic Excellence in a Young Patient with Adrenocortical Carcinoma: 10 Years of Remission. | JCEM Case Rep | 2025 | 40746503 | PubTator, text mining | PubMed |
| Nodule density on CT-scan correlates with CYP11B1 expression in a patient with ARMC5 mutated primary bilateral macronodular adrenal hyperplasia. | Diagn Pathol | 2025 | 40739578 | PubTator, text mining | PubMed |
| Pharmacodynamic effects of highly selective aldosterone synthase inhibitor vicadrostat in cynomolgus monkeys: Contrasting effects of once versus twice daily dosing. | J Pharmacol Exp Ther | 2025 | 40729782 | PubTator, text mining | PubMed |
| Indole selectively suppresses aldosterone overproduction via binding to the catalytic site of CYP11B2. | Biochem Pharmacol | 2025 | 40721010 | PubTator, text mining | PubMed |
| Development of a CYP11B2 imaging tracer for primary aldosteronism: basic evaluation of iodine- and fluorine-incorporated pyridinyldihydroquinolinone derivatives. | EJNMMI Radiopharm Chem | 2025 | 40618316 | PubTator, text mining | PubMed |
| Machine Learning and Large Language Models for Modeling Complex Toxicity Pathways and Predicting Steroidogenesis. | Environ Sci Technol | 2025 | 40576990 | PubTator, text mining | PubMed |
| Steroidomic Changes in the Cerebrospinal Fluid of Women with Multiple Sclerosis. | Int J Mol Sci | 2025 | 40565362 | PubTator, text mining | PubMed |
| Evaluating Mathematical Concordance Between Taxonomic and Functional Diversity Metrics in Benthic Macroinvertebrate Communities. | Biology (Basel) | 2025 | 40563943 | PubTator, text mining | PubMed |
| Adrenal causes of endocrine hypertension in childhood or adolescence. | J Endocrinol Invest | 2025 | 40540150 | PubTator, text mining | PubMed |
| A case of mineralocorticoid intermediate-producing sarcomatoid adrenal cortical carcinoma: case report and review of literature. | Endocr J | 2025 | 40533166 | PubTator, text mining | PubMed |
| [Molecular genetics in pediatric endocrinology: 35 years of research]. | Probl Endokrinol (Mosk) | 2025 | 40411325 | PubTator, text mining | PubMed |
| Immunohistochemical Analysis of CYP11B2 (Aldosterone Synthase) and Evaluation of the HISTALDO Classification in Patients with Primary Aldosteronism. | Curr Mol Med | 2025 | 40325812 | PubTator, text mining | PubMed |
| Toxicological profiling and diuretic potential of arbutin via aldosterone synthase gene inhibition. | Life Sci | 2025 | 40280300 | PubTator, text mining | PubMed |
| A CRISPR-based high-throughput screening system identifies bromodomain inhibitors as transcriptional suppressors of CYP11B1. | Biochem Biophys Res Commun | 2025 | 40215680 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1584/papers?page=4